Linder Adam, Arnold Ryan, Boyd John H, Zindovic Marko, Zindovic Igor, Lange Anna, Paulsson Magnus, Nyberg Patrik, Russell James A, Pritchard David, Christensson Bertil, Åkesson Per
1Department of Clinical Sciences, Division of Infection Medicine, Klinikgatan 1, Skåne University Hospital, Lund University, Lund, Sweden. 2Value Institute and Department of Emergency Medicine, Christiana Care Health System, Newark, DE. 3Centre for Heart Lung Innovation, Division of Critical Care Medicine, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada. 4Department of Infectious Diseases, Örebro University Hospital, Örebro, Sweden. 5Department of Translational Medicine, Lund University, Lund, Sweden. 6Department of Emergency Medicine, Linköping University Hospital, Linköping, Sweden. 7Axis-Shield Diagnostics, Dundee, GB, United Kingdom.
Crit Care Med. 2015 Nov;43(11):2378-86. doi: 10.1097/CCM.0000000000001265.
Early identification of patients with infection and at risk of developing severe disease with organ dysfunction remains a difficult challenge. We aimed to evaluate and validate the heparin-binding protein, a neutrophil-derived mediator of vascular leakage, as a prognostic biomarker for risk of progression to severe sepsis with circulatory failure in a multicenter setting.
A prospective international multicenter cohort study.
Seven different emergency departments in Sweden, Canada, and the United States.
Adult patients with a suspected infection and at least one of three clinical systemic inflammatory response syndrome criteria (excluding leukocyte count).
None.
Plasma levels of heparin-binding protein, procalcitonin, C-reactive protein, lactate, and leukocyte count were determined at admission and 12-24 hours after admission in 759 emergency department patients with suspected infection. Patients were defined depending on the presence of infection and organ dysfunction. Plasma samples from 104 emergency department patients with suspected sepsis collected at an independent center were used to validate the results. Of the 674 patients diagnosed with an infection, 487 did not have organ dysfunction at enrollment. Of these 487 patients, 141 (29%) developed organ dysfunction within the 72-hour study period; 78.0% of the latter patients had an elevated plasma heparin-binding protein level (>30 ng/mL) prior to development of organ dysfunction (median, 10.5 hr). Compared with other biomarkers, heparin-binding protein was the best predictor of progression to organ dysfunction (area under the receiver operating characteristic curve=0.80). The performance of heparin-binding protein was confirmed in the validation cohort.
In patients presenting at the emergency department, heparin-binding protein is an early indicator of infection-related organ dysfunction and a strong predictor of disease progression to severe sepsis within 72 hours.
早期识别感染患者以及有发生伴有器官功能障碍的严重疾病风险的患者仍然是一项艰巨的挑战。我们旨在评估和验证肝素结合蛋白(一种中性粒细胞衍生的血管渗漏介质)作为多中心环境下进展为伴有循环衰竭的严重脓毒症风险的预后生物标志物。
一项前瞻性国际多中心队列研究。
瑞典、加拿大和美国的七个不同急诊科。
疑似感染且符合三项临床全身炎症反应综合征标准中至少一项(不包括白细胞计数)的成年患者。
无。
在759例疑似感染的急诊科患者入院时及入院后12 - 24小时测定血浆肝素结合蛋白、降钙素原、C反应蛋白、乳酸和白细胞计数。根据是否存在感染和器官功能障碍对患者进行定义。在一个独立中心收集的104例疑似脓毒症的急诊科患者的血浆样本用于验证结果。在674例诊断为感染的患者中,487例在入组时没有器官功能障碍。在这487例患者中,141例(29%)在72小时研究期内出现器官功能障碍;在后者这些患者中,78.0%在器官功能障碍发生前血浆肝素结合蛋白水平升高(>30 ng/mL)(中位数,10.5小时)。与其他生物标志物相比,肝素结合蛋白是进展为器官功能障碍的最佳预测指标(受试者操作特征曲线下面积 = 0.80)。肝素结合蛋白的性能在验证队列中得到证实。
在急诊科就诊的患者中,肝素结合蛋白是感染相关器官功能障碍的早期指标,也是72小时内疾病进展为严重脓毒症的有力预测指标。